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1. Introduction
  With social progression and global aging, more elderly are 
affected by lung cancer and their morbidity and mortality present 
a significant increase. Surgery is an important treatment method 
for non-small cell lung cancer (NSCLC). However, because of 
degraded physiological function, variety of comorbidities, high 
risk of complications during operation and mortality among elderly 
patients[1], doctors as well as patients tend to give up surgery in 
consideration of age, especially when dealing with NSCLC patients 
aged over 80. This is one reason why elderly NSCLC patients can 
not be effectively treated. During January 1998 and December 
2011, 52 NSCLC patients over 80 years were admitted to our 
hospital and treated, hereby we summarized their clinical features, 
surgical methods, perioperative management and prognosis as 
follows.
 
2. Materials and methods
2.1. Clinical data
  Totally 52 patients, 39 males and 13 females, aged 80-90 years 
with mean age of 83.6 were selected. Preoperative examinations 
included routine blood test, liver and kidney function, chest 
X-ray, electrocardiogram, ultrasound echocardiography, 
abdominal B ultrasound, pulmonary function, cranial CT or MRI, 
chest and abdominal CT, whole body bone scan; some patients 
underwent fiberoptic bronchoscopy, CT-guided puncture or PET-
CT examination.  A clear preoperative diagnosis was made and 
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distant metastases were excluded. Lesions located in left upper 
lobe in 8 cases, left lower lobe in 4 cases, right upper lobe in 23 
cases, right middle lobe in 3 cases, right lower lobe in 14 cases.
  Preoperat ive abnormal  ECG was found in  29 cases 
(55.8%), including abnormal ST in 21 cases, bundle branch 
block in 9 cases, premature ventricular contractions in 5 
cases, and atrial fibrillation in 3 cases. Twelve cases were 
found 1 second forced expiratory volume or maximum 
voluntary ventilation <60% in pulmonary function test. 
Among all patients, 19 cases (36.5%) were found with one 
comorbidity, 21 cases (42.3%) with two comorbidities, 4 
cases (7.7%) with three and 8 cases (15.4%) without. The 
patients were accompanied with hypertension in 27 cases 
(51.9%), coronary heart disease in 19 cases (36.5%), chronic 
obstructive pulmonary disease (COPD) in 7 cases (13.5%), 
diabetes in 5 cases (9.6%), cerebral infarction in 2 cases 
(3.8%), postoperation for removal of gastric cancer in 1 case 
(1.9%), chronic nephritis in 1 case (1.9%). Twenty-seven 
cases (51.9%) had smoking history. Clinical symptoms 
included chronic cough in 16 cases (30.8%) [9 cases were 
found blood stained sputum (17.3%)], chest pain in 6 cases 
(11.5%), other discomfort in 10 cases (19.2%), and 20 cases 
(38.4%) discovered in physical examination. 
2.2. Perioperative management
  Once  admi t ted ,  a l l  pa t ien ts  were  dea l t  w i th  the i r 
accompanying diseases, and their blood pressure was 
controlled between 120-140/70-90 mmHg; to those with 
coronary  hear t  d i sease ,  vasod i la to r  and  myocard ia l 
n u t r i t i o n a l  m e d i c i n e  w e r e  g i v e n  a n d  a s p i r i n  w a s 
discontinued one week before operation; To those with 
arrhythmia, antiarrhythmic drugs were applied to restore 
sinus rhythm; Smokers were required to quit ,  and no 
smoking for at least 2 weeks before operation; To those 
who coughed and expectorated a lot, aerosol inhalation was 
given, and sputum culture and drug susceptibility test were 
conducted and antibiotics was used 3 days before operation. 
After operation, the monitoring of breathing, blood pressure, 
heart rate,  blood oxygen saturation should be carried 
out for more than three days, and antibiotics was used to 
prevent infection, aerosol inhalation was used to assist 
coughing and expectoration, nutritional support should 
be strengthened and the water and electrolyte balance 
should be maintained. Special attention should be paid to 
preoperative accompanying diseases, such as nourishing 
cardiac muscle and dilating coronary artery, so as to manage 
them effectively and timely.
2.3. Surgical methods
  Double-lumen endotracheal intubation was adopted in 
general intravenous anesthesia, and the contralateral lung 
was for ventilation. Anatomic lobectomy and lymph node 
dissection was done in 32 cases (65.4%), in which the left 
upper lobe resection was done in 5 cases, left lower lobe 
resection in 3 cases, right upper lobe resection in 15 cases, 
right middle lobe resection in 2 cases, and right lower 
lobe resection in 7 cases. Sub-lobectomy and systematic 
lymph node sampling was conducted in 20 cases (38.5%), 
including pulmonary wedge resection in 16 cases (30.8%) 
and lung segment resection in 4 cases (7.7%). The operation 
time ranged 45-210 min with an average of 120.00±56.94. 
Blood loss during operation was 50-300 mL with an average 
174.40±54.97.
2.4. Statistical methods
  SPSS software was applied. The enumeration data were 
processed by using χ
2
 test ;  Survival rate by Kaplan-
Meier method and log-rank test. P<0.05 was referred to as 
statistically significant difference.
3. Results
3.1. Pathologic results after operation
  The pathological types verified after operation: squamous 
cell carcinoma in 19 cases (36.5%), adenocarcinoma and 
bronchioloalveolar carcinoma in 10 cases (19.2%), pure 
bronchioloalveolar carcinoma in 9 cases (17.3%), adenocarcinoma 
in 8 cases (15.4%), adenosquamous carcinoma in 4 cases (7.7%), 
squamous cell carcinoma and large cell carcinoma in 2 cases 
(3.8%). Postoperative pathologic TNM staging: 栺a 27 cases 
(51.9%), 栺b 12 cases (23.1%), 栻a 8 cases (15.4%), 栻b 3 cases 
(5.8%), 栿a 2 cases (3.8%).  
3.2. Postoperative outcomes
  Postoperative complications occurred in 23 cases (44.2%). 
Arrhythmia happened in 15 cases (28.9%), including sinus 
tachycardia in 10 cases (19.2%), atrial fibrillation in 8 cases 
(15.4%),  premature ventricular contractions in 4 cases (7.7%); 
lung infection in 4 cases (7.7%) with one case of respiratory failure; 
atelectasis in 3 cases (5.8%); persistent air leak lung more than one 
week in 2 cases (3.8%); acute heart failure in 2 cases (3.8%); acute 
cerebral infarction in 1 case (1.9%); acute myocardial infarction 
cases (1.9%). Perioperative death occurred in 2 cases (3.8%), 
respectively due to acute myocardial infarction and respiratory 
failure caused by severe lung infection. The complication rate after 
lobectomy was 56.3% (18/32), while that after sub-lobecomy was 
25.0% (5/20), with significant difference (P<0.05). 
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3.3. Follow-up results
  All 52 patients were followed up until December 2011. 
The follow-up rate was 94.2%, with 3 lost cases. The 
postoperative 1-, 3- and 5-year survival rate was 87.1%, 
59.8% and 19.1%. The postoperative 1-, 3- and 5-year 
survival rate was 86.0%, 61.8% and 21.5% among the 
patients after lobectomy and was 89.0%, 58.3%, 18.7% 
among the patients undertaking sub-lobectomy, without 
significant difference (P>0.05).
4. Discussion
  Lung cancer is a malignant tumor of  global highest 
morbidity and mortality, in which NSCLC accounts for 
about 80%-85%. Lung cancer is a typical age-related 
disease. The median age of lung cancer has reached 71 
years in the United States[2]. China has gradually entered 
the aging society, and the incidence of lung cancer has kept 
increasing in the elderly. Organs decrease significantly 
in their functions after one enters into his/her seventies. 
Currently NSCLC happened in those over 70 is defined 
as elderly NSCLC domestically and abroad[2]. The super-
aged (over 80) patients with lung cancer account for 7.5%-
14% of total lung cancer patients[3,4]. However, there are no 
standard treatment options and corresponding guidelines 
specific for these elderly patients. 
  Most of elderly NSCLC patients have a long smoking history 
associated with chronic bronchitis, which is likely to lead 
to overlook of respiratory symptoms and delay in treatment. 
Therefore, the appearance of symptoms like chronic cough or 
abnormal cough, sputum stained with blood, might indicate 
lung cancer and necessary checks should be conducted. Out 
of 52 cases of elderly NSCLC in our study, 32 cases (61.6%) 
presented clinical symptoms, mainly cough, sputum stained 
with blood; another 20 cases (38.4%) were discovered by 
means of physical examination. The patients found by 
physical examination were at early stage of lung cancer, and 
quite different from those with onset of symptoms. So it is of 
importance for the elderly to conduct physical examination 
that is helpful in detecting early lesions and leaves more 
choice to the elderly for a more thorough treatment. 
  One prominent clinical feature of the elderly NSCLC 
is  var ie ty  o f  concurrent  d iseases ,  such as  d iabetes , 
c a r d i o v a s c u l a r  d i s e a s e ,  COPD,  a n d  e a c h  o f  t h e s e 
accompanying diseases has a negative impact on the length 
of survival time. Death caused by other conditions than lung 
cancer is one key characteristic of the super-aged NSCLC[5]. 
The degraded physiological functions of the elderly NSCLC 
patients may work properly under the non-stress state, but 
once shaken by anesthesia and surgery, they may soon lose 
their compensatory ability and result in organ failure. So 
the dealing with the elderly patients is more difficult than 
with young patients. Full preoperative preparation plays 
an important role in securing surgical safety and reducing 
postoperative complications. Out of 52 cases of super-aged 
NSCLC patients, 19 cases (36.5%) presented one concomitant 
disease, 21 cases (42.3%) presented two, 4 cases (7.7%) 
presented three, and eight cases (15.4%) presented none. 
The most common concomitant diseases are hypertension, 
coronary heart disease, and chronic bronchitis. To the 
smoking patients,  besides cessation before operation, 
respiratory function exercise as well as expectoration and 
control of airway inflammation by medication should be 
undertaken. The function of cardiac compensation in the 
elderly patients is weak, and will be further weakened 
or disordered by surgical stimulation and the functional 
changes of endocrine system and immune system. Therefore, 
polarized liquid can be used to protect myocardium before 
operation so as to adjust to the best systemic state for 
operation. 
  Surgical treatment is the most effective method for early NSCLC 
and presents an obvious advantage in prolonging the survival 
time compared with radiotherapy and chemotherapy alone. Sirbu 
reported the 2-year survival rate of lung cancer patients over 70 
years was 6% when they received non-surgical treatment, while 
it reached 35.6% when they underwent operation[6]. Suemitsu[7] 
regarded that surgical treatment is an important method for NSCLC 
among over 80 years, especially for those in early stage. The 
standard surgical treatment of NSCLC is lobectomy and systematic 
lymph node dissection. So far there is no surgical method specific 
for elderly NSCLC patients. What we are using for these patients is 
by following the general principle of  "maximal removal of tumor 
and maximal retention of normal tissues", lobectomy, lung segment 
or wedge resection are usually adopted and pneumoectomy or 
sleeve lobectomy is cautiously considered, after the patients' 
physical status and organ functions are fully considered. Some 
researchers reported phase I lung cancer patients older than 80 
years can undertake wedge resection of lesion; Pathologically N2 
patients aged over 80 should avoid surgery[8]. Mery et al[9] found 
that lobectomy was superior to wedge resection for lung cancer 
patients under age 65, but showed no significant impact on the 
long-term survival among patients over 71 years. It is through sub-
lobectomy only that the elderly patients with early lung cancer can 
obtain the similar outcome that lobectomy achieved[10]. Patients 
in our study underwent anatomical lobectomy and lymph node 
dissection in 32 cases (65.6%), sub-lobectomy and systematic 
lymph node sampling in 20 cases (38.4%) [pulmonary wedge 
resection in 16 cases (30.8%) and lung resection 4 cases (7.7%)]. 
The postoperative 1-, 3- and 5-year survival rate was 86.0%, 
61.8% and 21.5% after lobectomy and 89.0%, 58.3% and18.7% 
after sub-lobectomy, without significant difference between 
lobectomy and sub-lobectomy (P>0.05). As long as the patient's 
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physical conditions permit, radical lung resection should be 
considered[11]. If the lesions are at early stage and the patients have 
poor cardiopulmonary function, lung segment resection or wedge 
resection can be applied and would achieve better results.
  The reports on age impact on postoperative complications 
and mortality of lung cancer vary. Jaklitsch[12] reported the 
complication rate of 1 020 lung cancer patients 曒70 years 
was 19%-48% and their postoperative mortality was 1%-
22%. Schneider[11] reported mortality after lobectomy was 
closely related to age; the mortality after lobectomy was 
0.9% (8/919) among those below 65 years, 1.9% (9/486) 
among those between 65 to 75 years, and 4.0% (4/100) 
among those over 75. Zhao[13] reported the postoperative 
complication rate of 498 lung cancer patients over 70 was 
32.7% and the mortality rate was 3.4%. The results from 
Cerfolid research[14] showed that there were no significant 
differences in hospital stay days, severe complications 
and perioperative mortality between those NSCLC patients 
over 70 and below 70. In the patients of our study, the 
postoperative complication rate was 44.2% (23/52) and their 
mortality was 3.8% (2/52). The postoperative complications 
involving cardiovascular system and respiratory system 
were related to preoperative diseases, which suggests the 
importance of active and proper handling of those diseases 
before operation. Postoperative arrhythmia posed a high 
incidence, mostly supraventricular tachycardia and atrial 
fibrillation. Arrhythmia was related to pain from wound, 
hypovolemia, hypoxia, smoking history, arrhythmia history, 
postoperative atelectasis, and pulmonary infection. It would 
effectively reduce the incidence of arrhythmia through 
oxygen supply during operation, maintenance of stable 
blood pressure by reducing blood loss, lessening anesthetic 
and operation time, gentle operation to minimize traction on 
pulmonary hilus and squeeze on heart. 
  In conclusion, the surgical risk for the super-aged (over 
80) NSCLC patients is acceptable. Age alone is not a surgical 
contraindication. For those super-aged NSCLC patients, who 
are in good physical condition, with no serious concomitant 
diseases and in early stage of lung cancer, should undertake 
surgical treatment and better outcome can be expected. 
Conflict of interest statement
  We declare that we have no conflict of interest.
References
[1]   Finlayson E, Fan Z, Birkmeyer JD. Outcomes in octogenarians 
undergoing high-risk cancer operation: a national study. J Am 
Coll Surg 2007; 205(6): 729-734.
[2]   Vora N, Reckamp KL. Non-small cell lung cancer in the elderly: 
defining treatment options. Semin Oncol 2008; 35(6): 590-596.
[3]   Satoh H, Kurishima K, Nakamura R, Ishikawa H, Kagohashi 
K,.Ohara G, et al. Lung cancer in patients aged 80 years and over. 
Lung Cancer 2009; 65(1): 112-118.
[4]   Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, 
Taioli E, et al. Lung cancer in elderly patients: an analysis of the 
surveillance epidemiology, and end results database. J Clin Oncol 
2007; 25(35): 5570-5577.
[5]   Kenzaki K, Sakiyama S, Tomimoto H, Toba H, Nakagawa Y, 
Takizawa H,  et al. Clinical analysis of elderly paitents with 
primary lung cancer. Kyobu Geka 2010; 63(7): 519-523.
[6]   Sirbu H, Schreiner W, Dalichau H, Busch T. Surgery for non-
small cell carcinoma in geriatric patients: 15 year experience. 
Asian Cardiovasc Thorac Ann 2005; 13(4): 330-336.
[7]   Suemitsu R, Yamaguchi M, Takeo S, Hamatake M, Yoshino J, 
Motoyama M, et al. Favorable surgical results for patients with 
nonsmall cell lung cancer over 80 years old: a multicenter survey. 
Ann Thorac Cardiovasc Surg 2008; 14(3): 154-160.
[8]   Spaggiari I, Scanagatta P. Surgery of non-small cell lung cancer 
in the elderly. Curr Opin Oncol 2007; 19(2): 84-91.
[9]   Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker 
DJ, et al. Similar long-term survival of elderly patients with non-
small cell lung cancer treated with lobectomy or wedge resection 
within the surveillance, epidemilolgy and end results database. 
Chest 2005; 128: 237-245.
[10]  Okami J, Ito Y, Higashiyama M, Nakayama T, Tokunaga T, 
Maeda J, et al. Sublobar resection provides an equivalent survival 
after lobectomy in elderly patients with early lung cancer. Ann 
Thorac Surg 2010; 90(5): 1651-1656.
[11]  Schneider T, Pfannschmidt J, Muley T, Reimer P, Eberhardt R, 
Herth FJ, et al. A tretospective analysis of short and long-term 
survival after curative pulmonary resection for lung cancer in 
elderly patients. Lung Cancer 2008; 62(2): 221-227.
[12]  Jaklitsch MT, Mery CM, Audisio RA. The use of surgery to treat 
lung cancer in elderly patients. Lancet Oncol 2003; 4: 463-471.
[13]  Zhao SH, Liu XY, Zhang DC. Risk factors for mortality and major 
morbidity after lung cancer surgery in elderly patients aged 70 
years and over. Chinese J Geriatrics 2006; 25(9): 660-662.
[14]  Cerfolio RJ, Bryant AS. Survival and outcomes of pulmonary 
resection for non-small cell lung cancer in the elderly: a nested 
case-control study. Ann Thorac Surg 2006; 82: 424-429. 
